Hi Ralom - Have a look at note 15 to the Annual Financials - It discloses that, to 30/6/16 the cost to the company to own 72.8% of Admedus Vaccines P/l was just over $13m. We tipped in $3.5m last year to increase our holding but I don't believe we have contributed any further funds yet in this current financial year. There was an allowance in the last capital raising of $3m for further investment in the vaccine programs.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-71
-
- There are more pages in this discussion • 280 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |